BioCentury | Jul 3, 2020
Management Tracks

Angus Grant joins BeiGene; plus changes at Sarepta, RegenxBio, BioMarin, Novavax, Whitehead, Akcea and more

...where Kapoun was SVP of translational medicine. Mereo merged with OncoMed last year. Dermatology play Leo Pharma A/S...
...Research Akcea Therapeutics Inc. Oncopeptides AB Codiak BioSciences Inc. ImmVira Co. Ltd. Kyowa Kirin Co. Ltd. Inovio Pharmaceuticals Inc. Mereo BioPharma Group plc Leo Pharma A/S PDC*line...
BioCentury | Apr 16, 2020
Product Development

April 15 Quick Takes: TScan, Novartis team up on TCR therapies and a first for UroGen; plus Aligos, Leo, Madrigal, Merck

...to Develop Functional Cure for HBV” ). Leo gains rights to atopic dermatitis, asthma candidate Leo Pharma A/S...
...SB3 (Compound #), biosimilar trastuzumab (Generic), Ontruzant (Other) Samsung Bioepis Co. Ltd. Merck & Co. Inc. Madrigal Pharmaceuticals Inc. Leo Pharma A/S Novartis...
BioCentury | Dec 11, 2019
Clinical News

Leo’s IL-13 mAb hits in atopic dermatitis; how it stacks up against Dupixent remains a question mark

...Over a year after the primary completion of tralokinumab’s Phase III studies, Leo Pharma has said the...
...seen with Dupixent dupilumab from Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) and Sanofi (Euronext:SAN; NASDAQ:SNY). According to Leo Pharma A/S...
...date” for the trials were in August, September and October 2018, according to ClinicalTrials.gov. However, Leo Pharma...
BioCentury | Sep 20, 2019
Emerging Company Profile

Divide & Conquer: short-circuiting tumor lines of communication

...and is looking at other hard-to-treat tumor types such as pancreatic, lung and colorectal cancer. Leo Pharma A/S...
BioCentury | Aug 30, 2019
Politics & Policy

FDA urged to expand on integrated review

...the integrated review in additional public documents. For example, the U.S. subsidiary of dermatology company Leo Pharma A/S...
...inquiry regarding when it expects to finalize the review template. Allison Johnson, Senior Writer Dovato, dolutegravir/lamivudine Pifeltro, doravirine (MK-1439) Leo Pharma A/S Merck...
BioCentury | Jun 3, 2019
Company News

Management tracks: Zai, Jazz, PTC, BIO and more

...effective June 14. Gitte Aabo said she will step down as president and CEO of Leo Pharma A/S...
...pharmaceutical and preclinical sciences at Vertex Pharmaceuticals Inc. (NASDAQ:VRTX). Mark Zipkin, Staff Writer Biotechnology Industry Organization Jazz Pharmaceuticals plc Leo Pharma A/S Lyndra...
BioCentury | Mar 4, 2019
Company News

Management tracks: Astellas, Sanofi China, Zafgen

...Inc. (NASDAQ:BIIB), as well as interim global co-lead and SVP of global development. Dermatology company Leo Pharma A/S...
...SIX:ROG; OTCQX:RHHBY) acquired. Elizabeth S. Eaton, Staff Writer Astellas Pharma Inc. Constellation Pharmaceuticals Inc. DermTech International Inc. Fusion Pharmaceuticals Inc. ImaginAb Inc. Leo Pharma A/S Oric...
BioCentury | Nov 30, 2018
Company News

Leo Pharma invests in PellePharm to develop rare skin disease therapy

...Dermatology company Leo Pharma A/S (Ballerup, Denmark) gained an option to acquire PellePharm Inc. (Menlo Park, Calif.) and...
...Leo Pharma A/S, Ballerup, Denmark BridgeBio Pharma LLC, Palo Alto, Calif. Business: Dermatology Mary Romeo patidegib, saridegib (IPI-926) BridgeBio Pharma LLC Leo Pharma A/S PellePharm...
BioCentury | Nov 20, 2018
Company News

Leo Pharma invests in PellePharm to develop rare skin disease therapy

...Dermatology company Leo Pharma A/S (Ballerup, Denmark) gained an option to acquire PellePharm Inc. (Menlo Park, Calif.) and...
...board. PellePharm is a subsidiary of BridgeBio Pharma LLC (Palo Alto, Calif.). Mary Romeo patidegib, saridegib (IPI-926) BridgeBio Pharma Leo Pharma A/S PellePharm...
BioCentury | Nov 9, 2018
Tools & Techniques

HitGen’s DNA for small molecules

...InterX Inc. Co-development Viral infections Aug. 2017 Aduro Biotech Inc. (NASDAQ:ADRO) Screening Cancer Aug. 2017 Leo Pharma A/S...
Items per page:
1 - 10 of 186
BioCentury | Jul 3, 2020
Management Tracks

Angus Grant joins BeiGene; plus changes at Sarepta, RegenxBio, BioMarin, Novavax, Whitehead, Akcea and more

...where Kapoun was SVP of translational medicine. Mereo merged with OncoMed last year. Dermatology play Leo Pharma A/S...
...Research Akcea Therapeutics Inc. Oncopeptides AB Codiak BioSciences Inc. ImmVira Co. Ltd. Kyowa Kirin Co. Ltd. Inovio Pharmaceuticals Inc. Mereo BioPharma Group plc Leo Pharma A/S PDC*line...
BioCentury | Apr 16, 2020
Product Development

April 15 Quick Takes: TScan, Novartis team up on TCR therapies and a first for UroGen; plus Aligos, Leo, Madrigal, Merck

...to Develop Functional Cure for HBV” ). Leo gains rights to atopic dermatitis, asthma candidate Leo Pharma A/S...
...SB3 (Compound #), biosimilar trastuzumab (Generic), Ontruzant (Other) Samsung Bioepis Co. Ltd. Merck & Co. Inc. Madrigal Pharmaceuticals Inc. Leo Pharma A/S Novartis...
BioCentury | Dec 11, 2019
Clinical News

Leo’s IL-13 mAb hits in atopic dermatitis; how it stacks up against Dupixent remains a question mark

...Over a year after the primary completion of tralokinumab’s Phase III studies, Leo Pharma has said the...
...seen with Dupixent dupilumab from Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) and Sanofi (Euronext:SAN; NASDAQ:SNY). According to Leo Pharma A/S...
...date” for the trials were in August, September and October 2018, according to ClinicalTrials.gov. However, Leo Pharma...
BioCentury | Sep 20, 2019
Emerging Company Profile

Divide & Conquer: short-circuiting tumor lines of communication

...and is looking at other hard-to-treat tumor types such as pancreatic, lung and colorectal cancer. Leo Pharma A/S...
BioCentury | Aug 30, 2019
Politics & Policy

FDA urged to expand on integrated review

...the integrated review in additional public documents. For example, the U.S. subsidiary of dermatology company Leo Pharma A/S...
...inquiry regarding when it expects to finalize the review template. Allison Johnson, Senior Writer Dovato, dolutegravir/lamivudine Pifeltro, doravirine (MK-1439) Leo Pharma A/S Merck...
BioCentury | Jun 3, 2019
Company News

Management tracks: Zai, Jazz, PTC, BIO and more

...effective June 14. Gitte Aabo said she will step down as president and CEO of Leo Pharma A/S...
...pharmaceutical and preclinical sciences at Vertex Pharmaceuticals Inc. (NASDAQ:VRTX). Mark Zipkin, Staff Writer Biotechnology Industry Organization Jazz Pharmaceuticals plc Leo Pharma A/S Lyndra...
BioCentury | Mar 4, 2019
Company News

Management tracks: Astellas, Sanofi China, Zafgen

...Inc. (NASDAQ:BIIB), as well as interim global co-lead and SVP of global development. Dermatology company Leo Pharma A/S...
...SIX:ROG; OTCQX:RHHBY) acquired. Elizabeth S. Eaton, Staff Writer Astellas Pharma Inc. Constellation Pharmaceuticals Inc. DermTech International Inc. Fusion Pharmaceuticals Inc. ImaginAb Inc. Leo Pharma A/S Oric...
BioCentury | Nov 30, 2018
Company News

Leo Pharma invests in PellePharm to develop rare skin disease therapy

...Dermatology company Leo Pharma A/S (Ballerup, Denmark) gained an option to acquire PellePharm Inc. (Menlo Park, Calif.) and...
...Leo Pharma A/S, Ballerup, Denmark BridgeBio Pharma LLC, Palo Alto, Calif. Business: Dermatology Mary Romeo patidegib, saridegib (IPI-926) BridgeBio Pharma LLC Leo Pharma A/S PellePharm...
BioCentury | Nov 20, 2018
Company News

Leo Pharma invests in PellePharm to develop rare skin disease therapy

...Dermatology company Leo Pharma A/S (Ballerup, Denmark) gained an option to acquire PellePharm Inc. (Menlo Park, Calif.) and...
...board. PellePharm is a subsidiary of BridgeBio Pharma LLC (Palo Alto, Calif.). Mary Romeo patidegib, saridegib (IPI-926) BridgeBio Pharma Leo Pharma A/S PellePharm...
BioCentury | Nov 9, 2018
Tools & Techniques

HitGen’s DNA for small molecules

...InterX Inc. Co-development Viral infections Aug. 2017 Aduro Biotech Inc. (NASDAQ:ADRO) Screening Cancer Aug. 2017 Leo Pharma A/S...
Items per page:
1 - 10 of 186